Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
6 trials
Recent
Start date
Enrollment
Phase 3
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Oxaliplatin
×
Clear all
Filters
3
NCT05239741
2026-03-10
MK-3475-C66
Merck Sharp & Dohme LLC
Phase 3
Recruiting
100 enrolled
NCT03221426
2026-03-09
KEYNOTE-585
Merck Sharp & Dohme LLC
Phase 3
Completed
1,007 enrolled
25 charts
NCT05152147
2026-02-27
HERIZON-GEA-01
Jazz Pharmaceuticals
Phase 3
Active not recruiting
920 enrolled
NCT04949256
2025-12-15
MK-7902-014
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
864 enrolled
NCT04210115
2024-11-15
KEYNOTE 975
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
703 enrolled
NCT04859582
2021-12-16
KEYNOTE-859
Merck Sharp & Dohme LLC
Phase 3
Withdrawn